Terrence Blaschke
Terrence Blaschke
Professor of Medicine, Stanford University
Verified email at
Cited by
Cited by
Adherence to medication
L Osterberg, T Blaschke
New England journal of medicine 353 (5), 487-497, 2005
Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia
RH Böger, SM Bode-Böger, A Szuba, PS Tsao, JR Chan, O Tangphao, ...
Circulation 98 (18), 1842-1847, 1998
Sex differences in pharmacokinetics and pharmacodynamics
M Gandhi, F Aweeka, RM Greenblatt, TF Blaschke
Annu. Rev. Pharmacol. Toxicol. 44, 499-523, 2004
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047
CJ Fichtenbaum, JG Gerber, SL Rosenkranz, Y Segal, JA Aberg, ...
Aids 16 (4), 569-577, 2002
Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories
TF Blaschke, L Osterberg, B Vrijens, J Urquhart
Annual review of pharmacology and toxicology 52, 275-301, 2012
Protein binding and kinetics of drugs in liver diseases
TF Blaschke
Clinical Pharmacokinetics 2 (1), 32-44, 1977
Accelerated improvement of alcoholic liver disease with enteral nutrition
PJ Kearns, H Young, G Garcia, T Blaschke, G O'Hanlon, M Rinki, ...
Gastroenterology 102 (1), 200-205, 1992
Patient compliance and drug failure in protease inhibitor monotherapy
GF Vanhove, JM Schapiro, MA Winters, TC Merigan, TF Blaschke
Jama 276 (24), 1955-1956, 1996
Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man.
HY Pan, BB Hoffman, RA Pershe, TF Blaschke
Journal of Pharmacology and Experimental Therapeutics 239 (3), 802-807, 1986
Disposition of ketoconazole, an oral antifungal, in humans
C Brass, JN Galgiani, TF Blaschke, R Defelice, RA O'reilly, DA Stevens
Antimicrobial Agents and Chemotherapy 21 (1), 151-158, 1982
Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans
LJ Lesko, M Rowland, CC Peck, TF Blaschke
The Journal of Clinical Pharmacology 40 (8), 803-814, 2000
Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans
JR Chan, RH Böger, SM Bode-Böger, O Tangphao, PS Tsao, ...
Arteriosclerosis, thrombosis, and vascular biology 20 (4), 1040-1046, 2000
Updated guideline to perform therapeutic drug monitoring for antiretroviral agents.
CJL La Porte, D Back, T Blaschke, CAB Boucher, CV Fletcher, C Flexner, ...
Protein binding in antiretroviral therapies
M Boffito, DJ Back, TF Blaschke, M Rowland, RJ Bertz, JG Gerber, V Miller
AIDS research and human retroviruses 19 (9), 825-835, 2003
Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells.
CB Washington, GE Duran, MC Man, BI Sikic, TF Blaschke
Journal of acquired immune deficiency syndromes and human retrovirology …, 1998
The clinical pharmacokinetics of rifabutin
TF Blaschke, MH Skinner
Clinical Infectious Diseases 22 (Supplement_1), S15-S22, 1996
Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis
EA Neal, PJ Meffin, PB Gregory, TF Blaschke
Gastroenterology 77 (1), 96-102, 1979
Improving antiretroviral therapy adherence in resource‐limited settings at scale: a discussion of interventions and recommendations
JE Haberer, L Sabin, KR Amico, C Orrell, O Galárraga, AC Tsai, ...
Journal of the International AIDS Society 20 (1), 21371, 2017
Nicotine impairs endothelium‐dependent dilatation in human veins in vivo
S Chalon, H Moreno Jr, NL Benowitz, BB Hoffman, TF Blaschke
Clinical Pharmacology & Therapeutics 67 (4), 391-397, 2000
Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial
H Kastrissios, JR Suárez, D Katzenstein, P Girard, LB Sheiner, ...
Aids 12 (17), 2295-2303, 1998
The system can't perform the operation now. Try again later.
Articles 1–20